Biopsy Devices Market 2022 Global Industry Insights By Global Share, Emerging Trends, Regional Analysis, Segments, Drivers, Growth Factor

Precision Business Insights published a research report on “Biopsy Devices Market By Device Type (Core biopsy devices, Needle-based biopsy devices, Vacuum-assisted biopsy devices, Aspiration biopsy needles, Other), By Application (Gastrointestinal biopsy, Lung, Liver, Breast biopsy, Gynaecological, Kidney, Others), By Imaging Technologies (Ultrasound-guided biopsy, Stereotactic guided biopsy, CT scan, MRI guided biopsy, Others), By End User (Hospitals, Clinics, Diagnostic Centres) - Global/Region/Country Forecast to 2028”.

Biopsy devices are used by surgeons, radiologists, and other medical professionals to diagnose malignant and inflammatory disorders. These devices are utilised to avoid tissue fragmentation and artefact crushing. As a result of their small size and great sensitivity, they are frequently employed for MRI-guided, core and vacuum-assisted, and needle-based biopsies of various body areas.

View detailed report description here https://precisionbusinessinsights.com/market-reports/global-biopsy-devices-market/

Biopsy instruments are used to take a sample or a tissue of cells from the body to be examined in the lab for the presence of disease. The demand for biopsy devices is increasing as the incidence of cancer and the prevalence of various infectious diseases rises. The market will rise as people become more aware of breast cancer diagnosis and treatment. Furthermore, favourable reimbursement policies, as well as rising health-care expenditures, are boosting market growth. According to the American Cancer Society (ACS), overall cancer healthcare spending in the United States was at USD 220 billion in 2020 and is expected to reach USD 255 billion by 2030. As a result, rising cancer treatment and detection expenses, coupled with increasing number of cancer cases, will fuel the industry. Minimally invasive techniques are becoming more popular as technology develops in biopsy devices. The advancement of imaging technologies also including CT, ultrasound, and MRI has enabled healthcare providers to make more accurate diagnoses. As a result, the relative percentage of biopsies performed utilising imaging technologies will continue to climb during the forecast timeframe, based on current trends. The growing use of smart biopsy devices in numerous healthcare applications is one of the reasons driving the market forward. These smart biopsies have the potential to be used in a variety of therapeutic options as well. The expensive expense of invasive biopsies, as well as the pain associated with surgical procedures, has resulted in a considerable increase in the acceptance of smart biopsy instruments. As a result, factors such as real-time cancer tissue characterisation and low-cost smart biopsy instruments will propel the industry forward during the projection period.

On the basis of hyaluronic acid type, the biopsy devices market is categorized into procedure trays, localization wires, needle-based biopsy instruments, and other products. In terms of guidance technique, the biopsy devices market is classified into stereotactic-guided biopsy, ultrasound-guided biopsy, MRI-guided biopsy, and other guidance techniques. On the basis of application, the market is divided into lung biopsy, breast biopsy, colorectal biopsy, prostate biopsy, and other applications. In terms of end user, the biopsy devices market is fragmented into academic and research institutes, hospitals, and diagnostic and imaging centers.

Owing to the superior healthcare infrastructure, North America dominates the biopsy devices market. Due to the increased frequency of cancer and big populations in countries such as China and India, Asia-Pacific is predicted to grow significantly from 2022 to 2028.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=16664

Some of the major key players in the Biopsy Devices Market are Becton, Dickinson and Company (U.S.) Argon Medical Devices (U.S.) Cardinal Health, Inc. (U.S.) Boston Scientific Corporation (U.S.) Medtronic plc (Ireland) B. Braun Melsungen AG (Germany) Olympus Corporation (Japan) Hologic, Inc. (U.S.) SmartTarget Ltd. (U.K.) MDxHealth (Belgium) Intact Medical Corporation (U.S.)

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.